AI model study for lung nodule risk prediction
Part of Cancer, Lungs & breathing clinical trials.
This trial tests artificial intelligence (AI) models to predict whether a lung nodule found on a CT scan is likely cancerous. You may join if you have a nodule that will be biopsied or removed surgically, and your doctors can confirm its exact diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have at least one lung nodule on a chest CT scan, and it is no bigger than 3 cm across.
- The nodule will be biopsied or removed within 6 months of the CT scan.
- You have not had chemotherapy, radiation, or other treatments for this nodule between the CT scan and the biopsy/surgery.
- You do not have a history of other cancers (except non-small cell lung cancer).
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to predict how small lung nodules (called ground-glass nodules) will grow over time by analyzing repeated CT scans. The goal is to help doctors decide which nodules need surgery and which can be safely watched.
This study is testing a new method to help tell whether a lung nodule is benign (non-cancerous) or malignant (cancerous). It is for people who already need a biopsy or surgery for their lung nodule.
This study uses CT scans and medical records to build a model that helps tell the difference between benign (non-cancerous) and malignant (cancerous) solid lung nodules. It aims to improve diagnosis and reduce unnecessary surgeries.
This study collects information from your chest CT scans and medical history to build an artificial intelligence model of how your lungs work. This 'digital twin' may help doctors better understand and predict lung health in the future.
This study tests whether Optellum’s AI prediction tool can better identify which lung nodules found on CT scans are more likely to be cancer. You may be asked to provide specific types of CT images so the tool can be evaluated.
This trial uses photos of lung nodule tissue taken with a smartphone and analyzes them with artificial intelligence to improve diagnosis and predict outcomes. It may help people who are scheduled for lung surgery based on CT scans.
Hear when a new Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.